Inhibition of 2-oxoglutarate dependent oxygenases.

Symplectic ID
124346
Source
PubMed
This is the preferred source?
1
Last Synced with Symplectic
Sunday, 13 September, 2026 - 15:41
DOI
10.1039/c0cs00203h
Publication Date
Monday, 1 August, 2011
First Page
4364
Last Page
4397
Keywords
Collagen
Enzyme Inhibitors
Ethylenes
Gibberellins
Humans
Ketoglutaric Acids
Metals
Mixed Function Oxygenases
Procollagen-Proline Dioxygenase
Succinic Acid
gamma-Butyrobetaine Dioxygenase
Authors
Rose, NR
McDonough, MA
King, ONF
Kawamura, A
Schofield, CJ
Authors list has been truncated
0
Editors list has been truncated
Abstract
2-Oxoglutarate (2OG) dependent oxygenases are ubiquitous iron enzymes that couple substrate oxidation to the conversion of 2OG to succinate and carbon dioxide. In humans their roles include collagen biosynthesis, fatty acid metabolism, DNA repair, RNA and chromatin modifications, and hypoxic sensing. Commercial applications of 2OG oxygenase inhibitors began with plant growth retardants, and now extend to a clinically used pharmaceutical compound for cardioprotection. Several 2OG oxygenases are now being targeted for therapeutic intervention for diseases including anaemia, inflammation and cancer. In this critical review, we describe studies on the inhibition of 2OG oxygenases, focusing on small molecules, and discuss the potential of 2OG oxygenases as therapeutic targets (295 references).
Journal Title
Chem Soc Rev
eISSN
1460-4744
Volume
40
Issue
8
ID at Source
21390379
Publication Status
Published
Open access
Publication Date - Display month part?
Publication Date - Display day part?
SSO preference
cschof,phar0226